Additionally, the usefulness of a three-gene signature (PRKN, SRC and VDAC1) was evaluated based on genes related to mitophagy to predict survival in pancreatic cancer patients [26]. This evidence concerns the gene VDAC1 and familial pancreatic carcinoma.